Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56 | $39 | $273 | $227,723 |
| - Cash | $25,178 | $24,925 | $0 | $52,322 |
| + Debt | $152,247 | $122,355 | $0 | $154,162 |
| Enterprise Value | $127,125 | $97,469 | $273 | $329,563 |
| Revenue | $30 | $31 | $57,450 | $24,135 |
| % Growth | -5.1% | -99.9% | 138% | – |
| Gross Profit | -$2 | -$3 | $27,685 | $7,174 |
| % Margin | -6.3% | -9.1% | 48.2% | 29.7% |
| EBITDA | -$16 | -$16 | -$43,937 | -$26,275 |
| % Margin | -52.6% | -51.4% | -76.5% | -108.9% |
| Net Income | -$31 | -$37 | -$65,344 | -$35,736 |
| % Margin | -105.5% | -117.3% | -113.7% | -148.1% |
| EPS Diluted | -0.34 | -0.58 | -0.5 | -0.62 |
| % Growth | 41.4% | -16% | 19.4% | – |
| Operating Cash Flow | -$29 | -$21 | -$44,834 | -$32,858 |
| Capital Expenditures | -$0 | -$1 | -$1,936 | -$1,878 |
| Free Cash Flow | -$29 | -$22 | -$46,770 | -$34,736 |